News

August 11th, 2010

The final analysis of the GHSG HD10 trial will be published in the August issue of the New England Journal of Medicine. Parts of the published data will be presented at our conference.

August 1st, 2010

A total of 181 abstracts were received which is 20% up compared to the last Symposium

July 1st, 2010

Please note: The deadline for abstract submission has been extended to July 15th, 2010!

June 14th, 2010

The 8th International Symposium on Hodgkin Lymphoma will be certified by the ESMO with 18 ESMO-MORA points category 1.

May 21st, 2010

Landesärztekammer Nordrhein certifies the participation in this meeting with 18 credit points.

April 29th, 2010

Online abstract submission open!

April 1st, 2010

The Bonadonna Lecture at the opening ceremony will be held by Nobel Laureate Prof. H. zur Hausen.

March 13th, 2010

First German patient day established!

Topics

  • Basic Research
  • Early Stages
  • Advanced Stages
  • Transplantation
  • Survivorship
  • PET
  • New Drugs
  • Special Challenges in Hodgkin Lymphoma

Organization

Andreas Engert, M.D.,
Symposium Chairman, Chairman of the GHSG

Peter Borchmann, M.D,
Symposium Secretary

German Hodgkin Study Group (GHSG)
University Hospital of Cologne
Kerpener Str. 62
D-50924 Köln

German Hodgkin Study Group

8th International Symposium on Hodgkin Lymphoma

Outside view of the Gürzenich

October 2010

The 8th International Symposium on Hodgkin Lymphoma will take place in Cologne from

October 23rd to October 26th 2010


The event will again be held at the Gürzenich Cologne located just a couple of minutes away from the river Rhine and the world-famous cathedral.

On behalf of the German Hodgkin Study Group (GHSG) we cordially invite you to participate and contribute to this meeting. All major aspects of biology, molecular pathology, staging, treatment and survivor­ship will be covered. There will be a special emphasis on new biological aspects, innovative treatment approaches and survivorship. Innovative satellite symposia, scientific sessions and a number ofworkshops will complement the program. The Karl-Musshoff-Prize for outstanding achievements in the field of Hodgkin Lymphoma will be awarded during the conference.

We encourage you to contact us for further information and specific questions. You may also keep track on regular updates and additional details to the program via our website www.hodgkinsymposium.org. We very much look forward to welcoming you here in Cologne.

Andreas Engert, M.D.
Congress and GHSG Chairman

Peter Borchmann, M.D.
Congress and GHSG Secretary

Volker Diehl, M.D.
Honorary Chairman